Old Web
English
Sign In
Acemap
>
authorDetail
>
Koen van der Vijver
Koen van der Vijver
Netherlands Cancer Institute
Medicine
Cisplatin
Pathology
Oncology
Chemotherapy
3
Papers
42
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Adaptive phase II randomized trial of nivolumab after induction treatment in triple negative breast cancer (TONIC trial): Final response data stage I and first translational data.
2018
Journal of Clinical Oncology
Marleen Kok
Leonie Voorwerk
Hugo M. Horlings
Karolina Sikorska
Koen van der Vijver
Maarten Slagter
Sarah Warren
SuFey Ong
Terry Wiersma
Nicola S. Russell
Ferry Lalezari
Michiel de Maaker
Inge Kemper
I. A. M. Mandjes
Myriam Chalabi
Gabe S. Sonke
Roberto Salgado
Sabine C. Linn
Ton N. M. Schumacher
Christian U. Blank
Show All
Source
Cite
Save
Citations (24)
Towards omitting breast cancer surgery in select patient groups: Assessment of pathologic complete response after neoadjuvant systemic therapy using biopsies—The MICRA trial.
2017
Journal of Clinical Oncology
Marieke Van Der Noordaa
Frederieke van Duijnhoven
Claudette E. Loo
Koen van der Vijver
Gabe S. Sonke
Carmen C. van der Pol
Anne Brecht Francken
Marie-Jeanne T. F. D. Vrancken Peeters
Show All
Source
Cite
Save
Citations (3)
A phase 3 trial of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer.
2017
Journal of Clinical Oncology
Willemien J. van Driel
Karolina Sikorska
Jules H. Schagen van Leeuwen
Henk W.R. Schreuder
Ralph H. Hermans
Ignace H. de Hingh
Jacobus van der Velden
Henriette J.G. Arts
Massuger Leon
Arend G. J. Aalbers
J Verwaal Victor
Koen van der Vijver
Neil K. Aaronson
Gabe S. Sonke
Show All
Source
Cite
Save
Citations (15)
1